AI Article Synopsis

  • * Standard treatment for unresectable ACC typically involves radiotherapy, but delivering effective doses while protecting nearby healthy tissue can be challenging.
  • * This report discusses two cases where patients with ACC of the trachea received high-dose proton beam therapy (74 Gy) and experienced long-term survival.

Article Abstract

Adenoid cystic carcinoma (ACC) of the trachea is a rare disease that is slow growing and has a risk of distant metastasis. The standard treatment for ACC of the trachea is surgery, but this tumor is often unresectable. In definitive radiotherapy using photons for unresectable ACC of the trachea, it is sometimes difficult to deliver a sufficient dose to the target without exceeding the tolerable dose to the surrounding normal tissues. Here, we report two cases of ACC of the trachea that received a high dose (74 Gy [relative biological effectiveness]) of proton beam therapy and achieved long-term survival.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10788470PMC
http://dx.doi.org/10.1111/1759-7714.15158DOI Listing

Publication Analysis

Top Keywords

acc trachea
16
adenoid cystic
8
cystic carcinoma
8
proton beam
8
beam therapy
8
report cases
8
trachea
5
long-term follow-up
4
follow-up unresectable
4
unresectable adenoid
4

Similar Publications

Article Synopsis
  • * In cases where surgery isn't possible, a radiation dose of 60-70 Gy, sometimes combined with chemotherapy, is recommended as a treatment option, as demonstrated in a case involving online daily adaptive cone beam computed tomography (CBCT) radiotherapy.
  • * The study showed that using online adaptive radiotherapy (o-ART) improved target coverage and reduced damage to surrounding organs at risk (OAR) compared to traditional image-guided techniques, making it a promising approach for creating
View Article and Find Full Text PDF

Background/aim: Tracheobronchial adenoid cystic carcinoma (ACC) is a rare type of malignancy. Although complete resection is standard treatment for localized ACC, treatment for unresectable ACC has not been established. It is unclear whether concurrent chemoradiotherapy (CCRT) followed by immune checkpoint inhibitor (ICI) therapy is effective for ACC.

View Article and Find Full Text PDF

Tracheal adenoid cystic carcinoma with microscopic positive margin-how we approached with a systematic analysis review of its management.

Indian J Thorac Cardiovasc Surg

May 2024

Department of Surgery, Cardiothoracic Unit, University of Malaya Medical Centre (UMMC), Jalan University, 59100 Kuala Lumpur, Malaysia.

Purpose: Adenoid cystic carcinoma (ACC) of the trachea is a rare malignancy. We report a patient with ACC who underwent multimodal management including tracheal resection. A systematic review was also conducted on tracheal resection for ACC.

View Article and Find Full Text PDF

We present a case of an adenoid cystic carcinoma (ACC) located in the upper trachea, which resulted in significant airway blockage, that was unsuitable for surgical removal due to concerns about functional impairment. Instead, endotracheal enucleation via rigid bronchoscopy was performed initially, followed by the injection of a novel tumor ablation agent known as para-toluenesulfonamide (PTS). We detail the dosing regimen, effectiveness evaluation, and post-treatment follow-up.

View Article and Find Full Text PDF

Background: Primary tracheal tumors are very rare and the literature on this subject is limited. The most common histological type of primary tracheal tumors is squamous cell carcinoma (SCC), followed by adenoid cystic carcinoma (ACC). Limited knowledge exists regarding the behavior and outcomes of different histological types of tracheal cancers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!